[Skip to Navigation]
January 1991

Drug Response of Head and Neck Tumors in Native-State Histoculture

Author Affiliations

From the Division of Otolaryngology—Head and Neck Surgery (Drs Robbins and H. Hoffman), Laboratory of Cancer Biology, Department of Pediatrics (Dr R. M. Hoffman), and Division of Hematology and Oncology (Drs Storniolo and Varki), University of California School of Medicine, La Jolla; and the AntiCancer Inc, San Diego, Calif (Dr R. M. Hoffman).

Arch Otolaryngol Head Neck Surg. 1991;117(1):83-86. doi:10.1001/archotol.1991.01870130089022

• We describe a chemosensitivity testing of head and neck tumors, in which a native-state histoculture, ie, a three-dimensional culture system that maintains important in vivo properties, including tissue architecture, was used. Fifteen specimens of head and neck tumors were evaluated for sensitivity to the following drugs: cisplatin (DDP) at concentrations of 1.5, 15, and 37.5 μg/mL; fluorouracil at concentrations of 4.0, 40, and 100μg/mL; and combinations of cisplatin and fluorouracil in corresponding doses. Growth and measurement of drug responses were successfully completed in 10 specimens (five others were contaminated, four of them prior to instituting rigorous antibiotic washes). The results indicated cisplatin sensitivity in five of 10 patients; fluorouracil sensitivity in four of 10 patients; and fluorouracil-cisplatin sensitivity in seven of eight patients. Our preliminary results indicate that the native-state histoculture technique is feasible to test chemosensitivity of head and neck tumors.

(Arch Otolaryngol Head Neck Surg. 1991;117:83-86)

Add or change institution